Restricted Stock AwardRestricted Stock Award Agreement • February 25th, 2015 • Omnicare Inc • Retail-drug stores and proprietary stores
This AWARD AGREEMENT (this “Agreement”) is effective as of [DATE] (the “Grant Date”), by and between Omnicare, Inc., a Delaware corporation (“Omnicare” or the “Company”), and [NAME] (the “Participant”). The restricted stock award granted hereby is granted by the Compensation Committee (the “Committee”) of Omnicare’s Board of Directors pursuant to the terms of the 2014 Stock and Incentive Plan (the “Stock Plan”). This Agreement evidences the issuance or transfer of [NUMBER OF SHARES] shares of Common Stock (hereinafter sometimes called the “Restricted Shares”) to the Participant upon the terms and subject to the conditions set forth herein. All capitalized terms not defined in this Agreement shall have the meanings assigned to such terms in the Stock Plan.
OMNICARE, INC. Performance Restricted Stock Unit AwardPerformance Restricted Stock Unit Award • February 25th, 2015 • Omnicare Inc • Retail-drug stores and proprietary stores
This AWARD AGREEMENT (this “Agreement”) is effective as of [DATE] (the “Grant Date”), by and between Omnicare, Inc., a Delaware corporation (“Omnicare” or the “Company”), and [NAME] (the “Participant”). The performance restricted stock unit award granted hereby is granted by the Compensation Committee (the “Committee”) of Omnicare’s Board of Directors pursuant to the terms of the 2014 Stock and Incentive Plan (the “Stock Plan”). All capitalized terms not defined in this Agreement shall have the meanings assigned to such terms in the Stock Plan.
AMENDMENT NO. 1Credit Agreement • February 25th, 2015 • Omnicare Inc • Retail-drug stores and proprietary stores • New York
AMENDMENT NO. 1 (this “Amendment”), dated as of November 5, 2014, to that certain Amended and Restated Credit Agreement (dated September 28, 2012, as may be further amended, supplemented or otherwise modified from time to time, the “Credit Agreement”, with capitalized terms used herein and not defined herein having the meanings assigned to therein), among Omnicare, Inc., a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), SunTrust Bank, as Administrative Agent (the “Agent”), JPMorgan Chase Bank, N.A., as Syndication Agent, and Barclays Bank PLC, Goldman Sachs Bank USA, and Bank of America, N.A., as Co-Documentation Agents.
PHARMACEUTICAL PRIME VENDOR AGREEMENTPharmaceutical Prime Vendor Agreement • February 25th, 2015 • Omnicare Inc • Retail-drug stores and proprietary stores
THIS PHARMACEUTICAL PRIME VENDOR AGREEMENT (“Agreement”) is made and entered into as of the 1st day of January, 2015 (the “Effective Date”) by and between Omnicare, Inc. (“Omnicare”), a Delaware corporation with its principal place of business at 900 Omnicare Center, 201 E. Fourth Street, Cincinnati, Ohio 45202, and McKesson Corporation (“Vendor”), a Delaware corporation with its principal place of business at One Post Street, San Francisco, California 94104. Omnicare and Vendor are sometimes herein referred to individually as a “Party,” and collectively and the “Parties.”
